News
Virtuagym has raised $2.
Livongo Health, the diabetes management startup launched last year by former Allscripts CEO Glen Tullman, will roll out its platform to a large group of New Yorkers via the Mount Sinai health system.
Fitness tracking device developer Garmin has unveiled its first smart scale, called Index Smart Scale, to help its users track weight and related metrics.
IBM Research and Carnegie Mellon University are working on a smartphone app that would help blind and visually impaired people navigate their surroundings, by communicating information about the users surroundings to them via audio cues or vibrations.
Fitbit Surge
The Consumer Electronics Association (CEA), which puts on the massive CES event in Las Vegas every January, just published a set of voluntary guidelines for how technology companies should approach privacy and security for personal wellness data collected by wearable devices and other connected wellness devices.
The Right Place has raised $2 million from undisclosed angel investors for a mobile-enabled offering that helps skilled nursing facilities (SNF) with care coordination and patient placement.
Following up on their report on consumerism in healthcare, Rock Health Managing Director Malay Gandhi sat down with a few entrepreneurs that are trying to make direct-to-consumer business models in healthcare work.
Austin, Texas-based RxWiki, which offers a medication encyclopedia written and edited by pharmacists as well as tools to help community pharmacists to communicate with consumers, has raised $5.
The National Institute of Diabetes and Digestive Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), has awarded Providence's Miriam Hospital and Boston's Beth Israel Deaconess Medical Center a $1.
Nearly a year after announcing its direct-to-consumer fitness tracker AmpStrip -- and after raising more than $500,000 on Indiegogo for it -- Fitlinxx has announced that it will not be developing AmpStrip as a fitness tracker, but rather as a medical device.